SFX by Ex Libris Inc.

Title:	Structural disorder of monomeric alpha-synuclein persists in mammalian cells
Source:	Nature [0028-0836] Theillet, F X yr:2016

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Zarranz, Juan J J. "The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia." Annals of neurology 55.2 (2004): 164-73.
description	2.	SÃ¼dhof, Jacqueline C. "Properties of native brain Î±-synuclein." Nature 498.7453 (2013): -6.
description	3.	Baum, E B. "Bounds on the size of ultrametric structures." Physical review letters 56.15 (1986): 1598-1600.
description	4.	Bolintineanu, Dan S. "Multiscale Models of the Antimicrobial Peptide Protegrin-1 on Gram-Negative Bacteria Membranes." International journal of molecular sciences 13.9 (2012): 11000-11011.
description	5.	Kramer ML, Michael L L. "Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies." The journal of neuroscience 27.6 (2007): 1405-10.
description	6.	Singleton, A. "alpha-synuclein locus triplication causes Parkinson's disease." Science 302.5646 (2003): 841-841.
description	7.	Ibez, P. "Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease." The Lancet 364.9440 (2004): 1169-1171.
description	8.	Riess, O. "Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease." Nature genetics 18.2 (1998): 106-108.
description	9.	Selkoe, Dennis J. "α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation." Nature 477.7362 (2011): 107-10.
description	10.	Spillantini, M G G. "Alpha-synuclein in Lewy bodies." Nature 388.6645 (1997): 839-40.
description	11.	Braak, E. "Staging of brain pathology related to sporadic Parkinson's disease." Neurobiology of Aging 24.2 (2003): 197-211.
description	12.	Sulzer, D. "Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy." Science 305.5688 (2004): 1292-5.
description	13.	BAUM, J. "Multiple-Quantum NMR Study of Clustering in Hydrogenated Amorphous Silicon." Physical review letters 56.13 (1986): 1377-1380.
description	14.	Kim, C. "A Solid-state NMR Study of the Kinetics of the Activity of an Antimicrobial Peptide, PG-1 on Lipid Membranes." Bulletin of the Korean Chemical Society 33.2 (2012): 426-432.
description	15.	Biliouris, K. "Stochastic simulations of a synthetic bacteria-yeast ecosystem." BMC systems biology 6.1 (2012): 58-71.
description	16.	Sharma, M. "CSPα knockout causes neurodegeneration by impairing SNAP-25 function." EMBO journal 31.4 (2012): 829-841.
description	17.	Pasupuleti, M. "Antimicrobial peptides: key components of the innate immune system." Critical reviews in biotechnology 32.2 (2011): 143-171.
description	18.	Nishioka, K. "A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson disease." Journal of Neurology, Neurosurgery and Psychiatry 81.4 (2009): 391-395.
description	19.	Uversky, Vladimir N. "Biophysics of Parkinson's Disease: Structure and Aggregation of alpha-Synuclein." Current protein & peptide science 10.5 (2009): 483-499.
description	20.	Jasinska-Myga, B. "Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia." Archives of neurology 64.2 (2007): 261-5.